Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and effective therapy to improve glycemic control in patients with type 1 diabetes.
Epistemonikos ID: ce5aff2969b5991fb5e20858a5b2fa3199e9d764
First added on: May 12, 2024